DTIL
DTIL
NASDAQ · Biotechnology

Precision Biosciences Inc

$7.86
-0.06 (-0.76%)
As of Jun 30, 10:35 PM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +290.5% upside
Low Target $21.79
Average Target $30.69
High Target $37.55
Current Price $7.86
Current
$7.86
Target
$30.69
$21.79 $30.69 avg $37.55
Scenario Analysis
Bear Case
$21.79
177.2%
Low target
Base Case
$30.69
+290.5%
Avg target
Bull Case
$37.55
+377.7%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$8.82
-10.9% from high
52-Week Low
$3.53
+122.7% from low
Target vs 52W High
$30.69
+248.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +2.4%
AMGN
Amgen Inc
Hold 44 50% $190.87 -47.3%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +187.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -11.8%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -66.0%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -39.1%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -47.4%